Spyre Therapeutics, Inc SYRE 深 滬
等待開盤 06-25 09:30:00 美东时间
86.24
-10.810
-11.14%
華盛通- 最 高88.15
- 今 開83.22
- 成交量 404.47万股
- 最 低 81.65
- 昨 收 97.05
- 總市值 74.89亿
- 52周最高 102.06
- 市盈率 靜 --
- 換手率 4.66%
- 52周最低 14.505
- 委 比 97.80%
- 總股本 8684.13万
- 歷史最高 318.75
- 量 比 1.88
- 振 幅 6.70%
- 歷史最低 2.66
- 每 手 1
- 風險率 21.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With Spyre Therapeutics Stock On Wednesday?
Spyre Therapeutics Inc. (NASDAQ:SYRE) stock plunged more than 12% on Wednesday as investors reacted to large insider stock sales. The stock is up more than 160% year to date and over 450% over the past year. Insider Sales Weigh on Sentiment Fairmount Healthcare Fund II L.P., affiliated with company ...
06-24 23:56
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
Deutsche Bank Maintains Buy on Spyre Therapeutics, Raises Price Target to $135
Deutsche Bank analyst David Hoang maintains Spyre Therapeutics (NASDAQ:SYRE) with a Buy and raises the price target from $115 to $135.
06-23 21:37
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket
Shares of SAGTEC GLOBAL Ltd (NASDAQ:SAGT) gained 75.6% to $1.74 in pre-market trading after the Kuala Lumpur-based enterprise software firm issued financial year 2026 guidance projecting 35% revenue growth. Sagtec projected $25.78 million in revenue, up from $19.1 million in the financial year 2025....
06-22 17:21
